National Planning Corporation’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-33,580
| Closed | -$1.27M | – | 52 |
|
|
2017
Q3 | $1.27M | Sell |
33,580
-1,100
| -3% | -$41.4K | 0.11% | 200 |
|
|
2017
Q2 | $987K | Buy |
34,680
+2,500
| +8% | +$71.2K | 0.08% | 258 |
|
|
2017
Q1 | $1.08M | Buy |
32,180
+1,900
| +6% | +$63.7K | 0.08% | 229 |
|
|
2016
Q4 | $1.07M | Sell |
30,280
-400
| -1% | -$14.1K | 0.08% | 223 |
|
|
2016
Q3 | $705K | Buy |
30,680
+1,500
| +5% | +$34.5K | 0.06% | 287 |
|
|
2016
Q2 | $1.07M | Sell |
29,180
-50
| -0.2% | -$1.83K | 0.08% | 230 |
|
|
2016
Q1 | $808K | Buy |
+29,230
| New | +$808K | 0.07% | 270 |
|
|
2015
Q1 | – | Sell |
-1,200
| Closed | -$38.6K | – | 653 |
|
|
2014
Q4 | $38.6K | Buy |
+1,200
| New | +$38.6K | ﹤0.01% | 1392 |
|